We provide you with 20 years of free, institutional-grade data for TRVN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TRVN. Explore the full financial landscape of TRVN stock.
| Reported Date | CIK | Ticker | Type |
|---|
Trevena, Inc(NASDAQ:TRVN) 
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the m...
Website: http://www.trevena.com
Founded: 2007
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about TRVN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.